When | Session | Talk Title | Room |
---|---|---|---|
Wed-01 16:20 - 17:10 |
Mini-Oral Abstract Session — Immunosuppression and Tolerance 2 | KJ047 is a next generation CD40 ligand antibody designed for safe and durable immunosuppression in combination with IgG degrading enzymes | Auditorium |